INTERNATIONAL PATENT: GENZYME CORPORATION FILES APPLICATION FOR "TREATMENT OF HEMOPHILIA WITH FITUSIRAN"

GENEVA, Aug. 19 -- GENZYME CORPORATION (450 Water StreetCambridge, Massachusetts 02141) filed a patent application (PCT/US2025/015037) for "TREATMENT OF HEMOPHILIA WITH FITUSIRAN" on Feb 07, 2025. With publication no. WO/2025/171279, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AFONSO, Marion (c/o Sanofi, Patent Department46 avenue de la Grande Armee75017 Paris), DEMISSIE, Marek (c/o Sanofi, Patent Department450 Water StreetCambridge, Massachusetts 02141), DONG, Yingwen (c/o Sanofi, Patent Department450 Water StreetCam...